Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "New daily-persistent headache"
Show Display Options
Rank Status Study
1 Not yet recruiting OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study
Condition: New Daily Persistent Headache
Intervention: Drug: OnabotulinumtoxinA
2 Completed A Research Study To Compare Two Kinds Of Daily Headache
Condition: Migraine
Intervention:

Indicates status has not been verified in more than two years